B.K.S. Sastry

2.7k total citations · 1 hit paper
18 papers, 1.8k citations indexed

About

B.K.S. Sastry is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, B.K.S. Sastry has authored 18 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 11 papers in Cardiology and Cardiovascular Medicine and 6 papers in Genetics. Recurrent topics in B.K.S. Sastry's work include Pulmonary Hypertension Research and Treatments (16 papers), Heart Failure Treatment and Management (7 papers) and Vascular Anomalies and Treatments (6 papers). B.K.S. Sastry is often cited by papers focused on Pulmonary Hypertension Research and Treatments (16 papers), Heart Failure Treatment and Management (7 papers) and Vascular Anomalies and Treatments (6 papers). B.K.S. Sastry collaborates with scholars based in India, United States and France. B.K.S. Sastry's co-authors include C Narasimhan, N. Krishna Reddy, B.S. Raju, Tomás Pulido, Hossein Ardeschir Ghofrani, Richard N. Channick, Pavel Jansa, Sanjay Mehta, Rogério Souza and Adam Torbicki and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

B.K.S. Sastry

18 papers receiving 1.8k citations

Hit Papers

Macitentan and Morbidity and Mortality in Pulmonary Arter... 2013 2026 2017 2021 2013 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
    2013 948 citations Tomás Pulido, Richard N. Channick et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.K.S. Sastry India 10 1.6k 1.2k 339 196 168 18 1.8k
R. Wiedemann Germany 10 1.4k 0.9× 892 0.8× 306 0.9× 82 0.4× 114 0.7× 17 1.6k
Michael Ochan Kilama Italy 9 912 0.6× 871 0.7× 149 0.4× 81 0.4× 98 0.6× 16 1.3k
Maria M. Jöbsis United States 6 2.7k 1.6× 2.0k 1.7× 495 1.5× 279 1.4× 333 2.0× 6 3.0k
Linda Clayton United States 7 2.7k 1.6× 2.0k 1.7× 495 1.5× 311 1.6× 334 2.0× 10 2.9k
G Simonneau France 13 1.7k 1.1× 1.1k 0.9× 337 1.0× 196 1.0× 252 1.5× 42 2.0k
Clara Hjalmarsson Sweden 17 626 0.4× 549 0.5× 122 0.4× 155 0.8× 71 0.4× 42 1.1k
Todd M. Kolb United States 23 1.3k 0.8× 993 0.8× 118 0.3× 240 1.2× 58 0.3× 88 1.8k
Peter M. Steele Australia 12 1.5k 0.9× 1.6k 1.4× 204 0.6× 774 3.9× 112 0.7× 23 2.7k
Clive Handler United Kingdom 20 629 0.4× 609 0.5× 81 0.2× 124 0.6× 27 0.2× 64 1.4k
Nika Skoro‐Sajer Austria 22 1.6k 1.0× 1.2k 1.0× 466 1.4× 101 0.5× 111 0.7× 52 1.8k

Countries citing papers authored by B.K.S. Sastry

Since Specialization
Citations

This map shows the geographic impact of B.K.S. Sastry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.K.S. Sastry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.K.S. Sastry more than expected).

Fields of papers citing papers by B.K.S. Sastry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.K.S. Sastry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.K.S. Sastry. The network helps show where B.K.S. Sastry may publish in the future.

Co-authorship network of co-authors of B.K.S. Sastry

This figure shows the co-authorship network connecting the top 25 collaborators of B.K.S. Sastry. A scholar is included among the top collaborators of B.K.S. Sastry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.K.S. Sastry. B.K.S. Sastry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shore, Supriya, S Harikrishnan, B.K.S. Sastry, et al.. (2022). Current status and barriers in pulmonary hypertension care delivery in India: A qualitative analysis. Pulmonary Circulation. 12(2). e12094–e12094. 2 indexed citations
2.
Langleben, David, Richard N. Channick, Marion Delcroix, et al.. (2020). SAFETY AND EFFICACY OF MACITENTAN IN ELDERLY PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH): INSIGHTS FROM SERAPHIN. Journal of the American College of Cardiology. 75(11). 2090–2090. 2 indexed citations
3.
Torbicki, Adam, M. Bacchi, Marion Delcroix, et al.. (2019). Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases. Circulation Cardiovascular Quality and Outcomes. 12(5). e005095–e005095. 12 indexed citations
4.
Souza, Rogério, Richard N. Channick, Marion Delcroix, et al.. (2018). Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial. PLoS ONE. 13(3). e0193226–e0193226. 36 indexed citations
5.
Vizza, Carmine Dario, B.K.S. Sastry, Zeenat Safdar, et al.. (2017). Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension. BMC Pulmonary Medicine. 17(1). 44–44. 16 indexed citations
6.
7.
Simonneau, Gérald, Richard N. Channick, Marion Delcroix, et al.. (2015). Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. European Respiratory Journal. 46(6). 1711–1720. 29 indexed citations
8.
Channick, Richard N., Marion Delcroix, Hossein Ardeschir Ghofrani, et al.. (2014). Effect of Macitentan on Hospitalizations. JACC Heart Failure. 3(1). 1–8. 50 indexed citations
9.
Hasan, Ashfaq, et al.. (2014). Regression of pulmonary artery hypertension due to development of a pulmonary arteriovenous malformation. Indian Heart Journal. 66(5). 535–538. 3 indexed citations
10.
Sitbon, Olivier, Richard N. Channick, Marion Delcroix, et al.. (2014). Macitentan reduces the risk of morbidity and mortality irrespective of the presence or absence of right ventricular (RV) impairment: Results from the randomised SERAPHIN trial in pulmonary arterial hypertension (PAH). 44. 3419. 5 indexed citations
11.
Jansa, Pavel, Richard N. Channick, Marion Delcroix, et al.. (2013). Impact of macitentan on the health-related quality of life (HRQoL) in pulmonary arterial hypertension (PAH): Results from a long-term randomised controlled trial. European Respiratory Journal. 42(Suppl 57). P4075–P4075. 2 indexed citations
12.
Channick, Richard N., Marion Delcroix, Nazzareno Galiè, et al.. (2013). Reduction Of Pulmonary Arterial Hypertension (Pah)-Related Hospitalizations With Macitentan In The Randomized Controlled Trial Seraphin. Value in Health. 16(3). A231–A231. 3 indexed citations
13.
14.
Pulido, Tomás, Richard N. Channick, Marion Delcroix, et al.. (2013). Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension. New England Journal of Medicine. 369(9). 809–818. 948 indexed citations breakdown →
15.
Rubin, Lewis J., Tomás Pulido, Richard N. Channick, et al.. (2012). Effect of Macitentan on Morbidity and Mortality in Pulmonary Arterial Hypertension (PAH): Results From the SERAPHIN Trial. CHEST Journal. 142(4). 1026A–1026A. 22 indexed citations
16.
Barst, Robyn J., D. Dunbar Ivy, Guillermo Gaitan, et al.. (2011). A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension. Circulation. 125(2). 324–334. 266 indexed citations
17.
Sastry, B.K.S., C Narasimhan, N. Krishna Reddy, & B.S. Raju. (2004). Clinical efficacy of sildenafil in primary pulmonary hypertension. Journal of the American College of Cardiology. 43(7). 1149–1153. 369 indexed citations
18.
Sastry, B.K.S., et al.. (1994). An Unusual Complication During a Transesophageal Echocardiographic Procedure in a Patient with Left Ventricular Pseudoaneurysm. Echocardiography. 11(1). 51–54. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Wiedemann Breakdown of academic impact, for papers by Michael Ochan Kilama Breakdown of academic impact, for papers by Maria M. Jöbsis Breakdown of academic impact, for papers by Linda Clayton Breakdown of academic impact, for papers by G Simonneau Breakdown of academic impact, for papers by Clara Hjalmarsson Breakdown of academic impact, for papers by Todd M. Kolb Breakdown of academic impact, for papers by Peter M. Steele Breakdown of academic impact, for papers by Clive Handler Breakdown of academic impact, for papers by Nika Skoro‐Sajer
Rankless by CCL
2026